The 60 references in paper E. Anaev Kh., T. Anokhina N., M. Kushaeva E., A. Chuchalin G., Э. Анаев Х., Т. Анохина Н., М. Кушаева Э., А. Чучалин Г. (2014) “Неинвазивные биомаркеры хронической обструктивной болезни легких // Non-invasive biomarkers of chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2013:i:3:p:97-104

1
Fischer B.M., Pavlisko E., Voynow J.A. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int. J. Chron. Obstruct. Pulm. Dis. 2011; 6: 413–421.
(check this in PDF content)
2
Donaldson G.C., Seemungal T.A., Patel I.S. et al.Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995–2004.
(check this in PDF content)
3
Borrill Z.L., Roy K., Singh D.Exhaled breath condensate biomarkers in COPD. Eur. Respir. J. 2008; 32 (2): 472–486.
(check this in PDF content)
4
Koczulla A.R., Noeske S., Herr C. et al. Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients. Respir. Med. 2012; 106 (1): 120–126.
(check this in PDF content)
5
Gerritsen W.B., Asin J., Zanen P. et al. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir. Med. 2005; 99: 84–90.
(check this in PDF content)
6
Leigh R., Pizzichini M.M., Morris M.M. et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur. Respir. J. 2006; 27: 964–971.
(check this in PDF content)
7
Brightling C.E., McKenna S., Hargadon B. et al.Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005; 60: 193–198.
(check this in PDF content)
8
Hurst J.R., Donaldson G.C., Perera W.R. et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 174: 867–874.
(check this in PDF content)
9
Papaioannou A.I., Mazioti A., Kiropoulos T. et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir. Med. 2010; 104 (2): 275–282.
(check this in PDF content)
10
Horvath I., Hunt J., Barnes P.J. et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J. 2005; 26: 523–548.
(check this in PDF content)
11
Popov T.A. Human exhaled breath analysis. Ann. Allergy Asthma Immunol. 2011; 106 (6): 451–456.
(check this in PDF content)
12
Taylor D.R.Using biomarkers in the assessment of airways disease. J. Allergy Clin. Immunol. 2011; 128 (5): 927–934.
(check this in PDF content)
13
Hoffmeyer F., Raulf,Heimsoth M., Bruning T. Exhaled breath condensate and airway inflammation. Curr. Opin. Allergy Clin. Immunol. 2009; 9 (1): 16–22.
(check this in PDF content)
14
Lee W., Thomas P.S.Oxidative stress in COPD and its measurement through exhaled breath condensate. Clin. Transl. Sci. 2009; 2 (2): 150–155.
(check this in PDF content)
15
Garey K.W., Neuhauser M.M., Robbins R.A. et al.Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125: 22–26.
(check this in PDF content)
16
Kostikas K., Papatheodorou G., Psathakis K. et al. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124: 1373–1380.
(check this in PDF content)
17
Grob N.M., Aytekin M., Dweik R.A. Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J. Breath Res. 2008; 2 (3): 037004.
(check this in PDF content)
18
Montuschi P., Collins J.V., Ciabattoni G. et al.Exhaled 8isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am. J. Respir. Crit. Care Med. 2000; 162: 1175–1177.
(check this in PDF content)
19
Montuschi P., Kharitonov S.A., Ciabattoni G., Barnes P.J. Exhaled leukotrienes and prostaglandins in COPD. Thorax
(check this in PDF content)
20
3; 58: 585–588. 20.Lin J.L., Bonnichsen M.H., Nogeh E.U. et al. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Expert. Rev. Proteomics 2010; 7 (3): 361–372.
(check this in PDF content)
21
Родионов А.А., Ревельский А.И., Ревельский И.А. и др. Хроматомасс-спектрометрическое определение среднелетучих органических веществ в конденсате выдыхаемого воздуха. Масс-спектрометрия 2007; 4 (2): 143–148.
(check this in PDF content)
22
Fens N., Zwinderman A.H., van der Schee M.P. et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am. J. Respir. Crit. Care Med. 2009; 180 (11): 1076–1082.
(check this in PDF content)
23
Анохина Т.Н. Новые биомаркеры – среднелетучие метаболиты в конденсате выдыхаемого воздуха при бронОбзоры хиальной астме и хронической обструктивной болезни легких: Автореф. дис. ... канд. мед. наук. М.; 2012.
(check this in PDF content)
24
Laurentiis G., Paris D., Melck D. et al.Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur. Respir. J. 2008; 32: 1175–1183.
(check this in PDF content)
25
Nicholson J.K.Global systems biology, personalized medicine and molecular epidemiology. Mol. Syst. Biol. 2006; 2: 52.
(check this in PDF content)
26
Crameri R.The potential of proteomics and peptidomics for allergy and asthma research. Allergy 2005; 60 (10): 1227–1237.
(check this in PDF content)
27
Conrad D.H., Goyette J., Thomas P.S.Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. J. Gen. Intern. Med. 2008; 23 (Suppl. 1): 78–84.
(check this in PDF content)
28
Sepper R., Prikk K.Proteomics: is it an approach to understand the progression of chronic lung disorders? J. Proteome Res. 2004; 3 (2): 277–281.
(check this in PDF content)
29
Montuschi P., Kharitonov S.A., Barnes P.J.Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001; 120 (2): 496–501.
(check this in PDF content)
30
Liu J., Sandrini A., Thurston M.C. et al.Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. Respiration 2007; 74 (6): 617–623.
(check this in PDF content)
31
Ferreira I.M., Hazari M.S., Gutierrez C. et al.Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effect of inhaled beclomethasone. Am. J. Respir. Crit. Care Med. 2001; 164: 1012–1015.
(check this in PDF content)
32
Paredi P., Kharitonov S.A., Leak D. et al.Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 162 (2, Pt 1): 369–373.
(check this in PDF content)
33
Moser B., Bodrogi F., Eibl G. et al. Mass spectrometric profile of exhaled breath – field study by PTR-MS. Respir. Physiol. Neurobiol. 2005; 145: 295–300.
(check this in PDF content)
34
Dragonieri S., Schot R., Mertens B.J. et al.An electronic nose in the discrimination of patients with asthma and controls. J. Allergy Clin. Immunol. 2007; 120: 856–862.
(check this in PDF content)
35
Borrill Z., Starkey C., Vestbo J., Singh D. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur. Respir. J. 2005; 25: 269–274.
(check this in PDF content)
36
Анаев Э.Х., Чучалин А.Г. Конденсат выдыхаемого воздуха в диагностике и оценке эффективности лечения болезней органов дыхания. Пульмонология 2006; 4: 12–20.
(check this in PDF content)
37
Antus B., Barta I., Kullmann T. et al. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study. Am. J. Respir. Crit. Care Med. 2010; 182 (12): 1492–1497.
(check this in PDF content)
38
Kostikas K., Papatheodorou G., Ganas K. et al.pH in expired breath condensate of patients with inflammatory airway diseases. Am. J. Respir. Crit. Care Med. 2002; 165: 1364–1370.
(check this in PDF content)
39
Corradi M., Montuschi P., Donnelly L.E. et al.Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am. J. Respir. Crit. Care Med. 2001; 163: 854–858.
(check this in PDF content)
40
Antczak A., Ciebiada M., Pietras T. et al.Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease. Arch. Med. Sci. 2012; 8 (2): 277–285.
(check this in PDF content)
41
Montuschi P., Macagno F., Parente P. et al. Effects of cyclooxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 2005; 60: 827–833.
(check this in PDF content)
42
Biernacki W.A., Kharitonov S.A., Barnes P.J.Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003; 58: 294–298.
(check this in PDF content)
43
Papi A., Bellettato C.M., Braccioni F. et al.Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 2006; 173: 1114–1121.
(check this in PDF content)
44
Ko F.W., Lau C.Y., Leung T.F. et al.Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respir. Med. 2006; 100: 630–638.
(check this in PDF content)
45
Nowak D., Kasielski M., Antczak A. et al.Increased content of thiobarbituric acid reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir. Med. 1999; 93: 389–396.
(check this in PDF content)
46
Dekhuijzen P.N., Aben K.K., Dekker I. et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996; 154: 813–816.
(check this in PDF content)
47
Beurden W.J., Harff G.A., Dekhuijzen P.N. et al. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003; 70: 242–248.
(check this in PDF content)
48
Kasielski M., Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir. Med. 2001; 95: 448–456.
(check this in PDF content)
49
Carpagnano G.E., Foschino Barbaro M.P., Cagnazzo M. et al. Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge. Chest 2005; 128: 3159–3166.
(check this in PDF content)
50
Carpagnano G.E., Kharitonov S.A., Foschino,Barbaro M.P. et al. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur. Respir. J. 2003; 21: 589–593.
(check this in PDF content)
51
Gessner C., Scheibe R., Wotzel M. et al.Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir. Med. 2005; 99: 1229–1240.
(check this in PDF content)
52
Ko F.W., Leung T.F., Wong G.W. et al. Measurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulm. Dis. 2009; 4: 79–86.
(check this in PDF content)
53
Bucchioni E., Kharitonov S.A., Allegra L., Barnes P.J. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir. Med. 2003; 97 (12): 1299–1302.
(check this in PDF content)
54
Курова В.С., Анаев Э.Х., Кононихин А.С. и др.Массспектрометрический мониторинг белкового состава конденсата выдыхаемого воздуха больного, перенесшего трансплантацию легких. Изв. РАН. Сер. хим. 2010; 1: 284–288.
(check this in PDF content)
55
Анаев Э.Х., Кушаева М.Э., Курова В.С. и др.Значение протеомного анализа конденсата выдыхаемого воздуха при диагностике ХОБЛ и пневмонии. Пульмонология 2012; 5: 5–9.
(check this in PDF content)
56
Bartoli M.L., Novelli F., Costa F. et al. Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm. 2011: 891752. doi: 10.1155/2011/891752.
(check this in PDF content)
57
Schumann C., Triantafilou K., Krueger S. et al. Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array. Mediators Inflamm. 2006: 18061.
(check this in PDF content)
58
Tateosian N.L., Costa M.J., Guerrieri D. et al. Inflammatory mediators in exhaled breath condensate of healthy donors and exacerbated COPD patients. Cytokine 2012; 58 (3): 361–367.
(check this in PDF content)
59
Esther C.R., Lazaar A.L., Bordonali E. et al. Elevated airway purines in COPD. Chest 2011; 140 (4): 954–960.
(check this in PDF content)
60
Corradi M., Acampa O., Goldoni M. et al.Metallic elements in exhaled breath condensate and serum of patients with exacerbation of chronic obstructive pulmonary disease. Metallomics. 2009; 1 (4): 339–345. Информация об авторах
(check this in PDF content)